These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3181442)

  • 21. [Tumor markers in the follow-up of colorectal cancers].
    Richelme H; Chazal M; Namer M; Benchimol D
    Chirurgie; 1993-1994; 119(6-7):346-8. PubMed ID: 7805492
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunoscintigraphy and SPECT in patients with pancreatic cancer].
    Montz R; Klapdor R; Kremer B; Rothe B
    Nuklearmedizin; 1985 Dec; 24(5-6):232-7. PubMed ID: 3879350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
    Talbot RW; Nagorney DM; Pemberton JH; Wieand HS; Ritts RE
    Cancer Res; 1989 Feb; 49(3):542-3. PubMed ID: 2910474
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical significance of a new monoclonal antibody defined antigen CA195 as a tumor marker in colorectal cancer.
    Shiue JW; Tam TN; Lai KH; Jeng FS; Liu RS; Yeh SH; Lee SD; Tsai YT
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Oct; 44(4):223-8. PubMed ID: 2634457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab')2.
    Aprile C; Prati U; Saponaro R; Roveda L; Carena M; Gastaldo L
    Int J Rad Appl Instrum B; 1991; 18(1):51-2. PubMed ID: 2010306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoscintigraphy of colon carcinoma.
    Chatal JF; Saccavini JC; Fumoleau P; Douillard JY; Curtet C; Kremer M; Le Mevel B; Koprowski H
    J Nucl Med; 1984 Mar; 25(3):307-14. PubMed ID: 6366160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-111 monoclonal antibody immunoscintigraphy of colorectal cancer.
    Lamki LM; Patt YZ; Murray JL
    Cancer Treat Res; 1990; 51():293-312. PubMed ID: 1977451
    [No Abstract]   [Full Text] [Related]  

  • 28. [Immunoscintigraphy and radioimmunotherapy of transplanted pancreatic carcinoma. Experimental animal studies with 131I-labeled monoclonal antibodies against CA 19-9, CEA and CA 125].
    Klapdor R; Montz R; Greten H; Chatal JF; Douillard JY; Saccavini JC; Dietel M
    Nuklearmedizin; 1985 Dec; 24(5-6):227-31. PubMed ID: 3867855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer.
    Wong JY; Chu DZ; Williams LE; Yamauchi DM; Ikle DN; Kwok CS; Liu A; Wilczynski S; Colcher D; Yazaki PJ; Shively JE; Wu AM; Raubitschek AA
    Clin Cancer Res; 2004 Aug; 10(15):5014-21. PubMed ID: 15297402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc.
    Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC
    Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoscintigraphy of primary and metastatic colorectal cancers with radiolabelled monoclonal antibodies anti-CEA.
    Riva P; Moscatelli G; Agostini M; Spinelli A; Franceschi G
    Acta Gastroenterol Belg; 1989; 52(5-6):497-505. PubMed ID: 2486018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoscintigraphy of colorectal carcinoma with an anti-CEA monoclonal antibody: a critical review.
    Buraggi GL; Gasparini M; Seregni E
    Int J Rad Appl Instrum B; 1991; 18(1):45-50. PubMed ID: 2010305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of combined use of CEA, CA19-9 and CA50 in the serum of patients with pancreatic carcinoma.
    Lucarotti ME; Habib NA; Kelly SB; Rothnie ND; Nelson O; Lindholm L; Cooper MJ; Wood CB; Williamson RC
    Eur J Surg Oncol; 1991 Feb; 17(1):51-3. PubMed ID: 1995358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of carcinoembryonic antigen and carbohydrate antigen (CA19-9) in pure pancreatic juice and sera in a patient with occult pancreatic cancer.
    Okai T; Sawabu N; Takemori Y; Ohta H; Motoo Y; Kidani H
    J Clin Gastroenterol; 1992 Sep; 15(2):162-4. PubMed ID: 1401832
    [No Abstract]   [Full Text] [Related]  

  • 35. Improved radioimaging and tumor localization with monoclonal F(ab')2.
    Wahl RL; Parker CW; Philpott GW
    J Nucl Med; 1983 Apr; 24(4):316-25. PubMed ID: 6339689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Does immunoscintigraphy improve early diagnosis of metastatic or recurrent cancer?].
    Hölting T; Steinbächer M; Kretzschmar U; Georgi P; Schlag P
    Onkologie; 1989 Aug; 12 Suppl 1():20-5. PubMed ID: 2685691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.
    Bischof-Delaloye A; Delaloye B; Buchegger F; Gilgien W; Studer A; Curchod S; Givel JC; Mosimann F; Pettavel J; Mach JP
    J Nucl Med; 1989 Oct; 30(10):1646-56. PubMed ID: 2795205
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
    Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
    J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Localization of human colorectal carcinoma xenografts in mice using radiolabeled monoclonal antibody to carcinoembryonic antigen.
    Tsai LC; Chen HM; Yeh SH; Yuan CC; Tsao D; Han SH
    Diagn Clin Immunol; 1988; 5(6):332-7. PubMed ID: 3219783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.
    Delaloye B; Bischof-Delaloye A; Buchegger F; von Fliedner V; Grob JP; Volant JC; Pettavel J; Mach JP
    J Clin Invest; 1986 Jan; 77(1):301-11. PubMed ID: 3484753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.